Published in Lancet on April 18, 1970
Treatment of Goodpasture syndrome with cyclophosphamide, prednisone and plasma exchange transfusions. Clin Exp Immunol (1976) 0.88
Continuous-flow plasmapheresis in management of severe rhesus disease. Br Med J (1977) 0.84
Antigen recognition by T-cells and its suppression. Significance and origin of rosette-forming cells. Ann Rheum Dis (1971) 0.83
Mechanism of Rh prophylaxis: an experimental study on specificity of immunosuppression. Br Med J (1975) 0.81
Adverse effect of plasma exchange on anti-D production in rhesus immunisation owing to removal of inhibitory factors. Br Med J (1980) 0.80
Rhesus haemolytic disease. J Clin Pathol Suppl (R Coll Pathol) (1976) 0.79
Potential for plasma exchange in children. Arch Dis Child (1982) 0.76
Extracorporeal immunoadsorption of myeloma IgG and autoimmune antibodies: a clinically feasible modality of treatment. Clin Exp Immunol (1980) 0.75
Hereditary disease and its control. Br Med J (1975) 0.75
ABO blood groups and abortion. Br Med J (1972) 0.75
Plasmapheresis. Br Med J (1978) 0.75
Intrauterine fetal transfusion. Br Med J (1977) 0.75
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 8.59
Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ (1997) 5.80
Death certification. Br Med J (Clin Res Ed) (1983) 3.47
The estimation of the concentration and equilibrium constant of anti-D. Immunology (1967) 3.44
Rh-immunization by pregnancy: results of a survey and their relevance to prophylactic therapy. Br Med J (1968) 3.31
The use of purified 125-I-labelled anti-gamma globulin in the determination of the number of D antigen sites on red cells of different phenotypes. Vox Sang (1966) 3.22
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science (1988) 3.03
Biochemical and haematological markers of alcohol intake. Lancet (1978) 2.96
First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment Cesarean section scar. Ultrasound Obstet Gynecol (2003) 2.62
The international spread of methicillin-resistant Staphylococcus aureus. J Hosp Infect (1987) 2.46
Deaths from Rh haemolytic disease in England and Wales in 1988 and 1989. BMJ (1991) 2.45
Prevention of Rh-haemolytic disease. Br Med J (1967) 2.37
Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med (1999) 2.35
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet (1998) 2.26
Immortalized B lymphocytes produce B-cell growth factor. Nature (1984) 2.23
The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem (1995) 2.20
Failure of a Relatively Small Dose of Passively Administered Anti-Rh to Suppress Primary Immunization by a Relatively Large Dose of Rh-positive Red Cells. Br Med J (1968) 2.15
Quantitative measurements concerning A and B antigen sites. Vox Sang (1967) 2.08
Human anti-self antibodies with high specificity from phage display libraries. EMBO J (1993) 2.08
Clearance of Rh D-positive red cells with monoclonal anti-D. Lancet (1990) 2.04
The native rat olfactory cyclic nucleotide-gated channel is composed of three distinct subunits. J Neurosci (1999) 1.93
Clearance of Rh-positive red cells by low concentrations of Rh antibody. Immunology (1967) 1.92
Effect of pregnancy on the isoantibody response in rabbits. Nature (1971) 1.91
Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant (2010) 1.84
Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed? Br J Obstet Gynaecol (1997) 1.83
Prevention of Rh-haemolytic disease: results of the Liverpool "low-risk" clinical trial. Br Med J (1971) 1.83
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum Mol Genet (2001) 1.81
Dose of anti-D gamma-globulin in prevention of Rh-haemolytic disease of the newborn. Br Med J (1966) 1.79
Volume-induced increase of anion permeability in human lymphocytes. J Gen Physiol (1982) 1.78
Naturally occurring anti-tissue antibodies in rat sera. Clin Exp Immunol (1966) 1.75
Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A (1997) 1.75
Prevention of rhesus iso-immunisation. Lancet (1968) 1.69
Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus. J Exp Med (1984) 1.69
JCAH accreditation and the hospital library: a guide for librarians. Bull Med Libr Assoc (1980) 1.68
The role of exoenzyme S in infections with Pseudomonas aeruginosa. J Infect Dis (1985) 1.68
Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation (1999) 1.67
The anti-D content of IgG preparations for use in the prevention of Rh haemolytic disease. Vox Sang (1968) 1.67
IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol (1981) 1.66
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes. Clin Exp Immunol (1980) 1.66
Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol (1995) 1.61
Initiation of complement activation. Springer Semin Immunopathol (1984) 1.54
Cesarean scar pregnancy. Ultrasound Obstet Gynecol (2003) 1.53
Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee. Ann Rheum Dis (2000) 1.52
The suppressive effect of carrier priming on the response to a hapten-carrier conjugate. Eur J Immunol (1974) 1.50
Suppression of primary RH immunization by passively-administered antibody. Experiments in volunteers. Vox Sang (1969) 1.50
Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies. Ann Rheum Dis (1987) 1.49
Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol (1990) 1.48
Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl (2001) 1.46
Metabolism of human immunoglobulin D (IgD). J Clin Invest (1966) 1.46
Assessment of intervention outcome in the absence of baseline data: 'reconstruction' of condom use time trends using retrospective analysis of survey data. Sex Transm Infect (2010) 1.44
Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study. Ann Intern Med (1978) 1.44
ABO blood groups in gastric bleeding. Gut (1966) 1.44
Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol (2007) 1.42
Splintage for congenital dislocation of the hip. Is it safe and reliable? J Bone Joint Surg Br (1987) 1.41
Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J Am Soc Nephrol (2000) 1.41
Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology (N Y) (1993) 1.40
Medical genetics in China. J Med Genet (1979) 1.39
Microplate ELISA for detection of antibodies to DNA in patients with systemic lupus erythematosus: specificity and correlation with Farr radioimmunoassay. J Clin Lab Anal (1989) 1.39
Effectiveness of RSV-IG in premature infants: potential pitfalls in clinical settings. Pediatrics (1998) 1.39
The benefits of mammography are not limited to women of ages older than 50 years. Cancer (1998) 1.39
Rat erythrocyte-induced anti-erythrocyte autoantibody production and control in normal mice. Immunol Rev (1981) 1.38
Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum (1997) 1.35
The serology of autologous immune complex nephritis in the rat. Clin Exp Immunol (1969) 1.33
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
Activation of Na+/H+ exchange in lymphocytes by osmotically induced volume changes and by cytoplasmic acidification. J Gen Physiol (1983) 1.32
'Pink spot' in the urine of schizophrenics. Nature (1965) 1.32
IgG antibodies to Aspergillus fumigatus in cystic fibrosis: a laboratory correlate of disease activity. Arch Dis Child (1988) 1.30
The Caenorhabditis elegans seven-transmembrane protein ODR-10 functions as an odorant receptor in mammalian cells. Proc Natl Acad Sci U S A (1997) 1.28
Senescence of a human lymphoblastoid clone producing anti-Rhesus(D). Eur J Immunol (1985) 1.27
Nomenclature for ion channel subunits. Science (2001) 1.26
The preparation and properties of monoclonal antibodies against human granulocyte membrane antigens. Br J Haematol (1981) 1.26
Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2. J Virol (1991) 1.25
The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules. Immunology (1978) 1.25
Age-related alterations in potentiation in the CA1 region in F344 rats. Neurobiol Aging (1993) 1.24
Molecular characterization of the cellular receptor for poliovirus. Virology (1994) 1.23
IgG antiglobulins in rheumatoid arthritis and other arthritides: relationship with clinical features and other parameters. Ann Rheum Dis (1981) 1.23
Haemoglobin and red cell enzyme changes in juvenile myeloid leukaemia. Br Med J (1968) 1.23
Normal values of transfer factor and transfer coefficients in healthy males and females. Respiration (1979) 1.22
Lung immunoglobulins in the sudden infant death syndrome. BMJ (1989) 1.22
Direct activation of neutrophil chemiluminescence by rheumatoid sera and synovial fluid. Ann Rheum Dis (1983) 1.22
The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg (1992) 1.22
Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution? Trends Immunol (2001) 1.20
Response of the rheumatoid synovial membrane to exogenous immunization. J Clin Invest (1971) 1.20
In vivo and in vitro studies of telomeres and telomerase. Cold Spring Harb Symp Quant Biol (1993) 1.19
The effect of capping by anti-immunoglobulin antibody on the expression of cell surface immunoglobulin and on lymphocyte activation. Scand J Immunol (1973) 1.19
1 alpha,25-(OH)2-vitamin D3 analogs with minimal in vivo calcemic activity can stimulate significant transepithelial calcium transport and mRNA expression in vitro. Arch Biochem Biophys (1996) 1.19
Diurnal variation of lymphocyte subsets identified by monoclonal antibodies. Br Med J (Clin Res Ed) (1983) 1.18
Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritis. Genes Immun (2004) 1.18
Cerebral and orbital Aspergillus infection due to invasive aspergillosis of ethmoid sinus. J Clin Pathol (1986) 1.17
Membrane antigens of human cells of the monocyte/macrophage lineage studied with monoclonal antibodies. Pathology (1983) 1.17
Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. IV. A monoclonal antibody reacting specifically with a subpopulation of human B lymphocytes. J Immunol (1981) 1.17
Functional half-life of virgin and primed B lymphocytes. Eur J Immunol (1976) 1.16
Receptors that couple to 2 classes of G proteins increase cAMP and activate CFTR expressed in Xenopus oocytes. Receptors Channels (1993) 1.15
Routine quantification of rheumatoid factor by rate nephelometry. Ann Rheum Dis (1985) 1.15
The functional activities of IgG and IgM anti-A and anti-B. Immunology (1967) 1.14
The isolation of immune complexes containing IgM rheumatoid factor and recovery of IgG rheumatoid factor from the complexes. J Immunol Methods (1980) 1.14
Enhanced oxidative response of polymorphonuclear leukocytes from synovial fluids of patients with rheumatoid arthritis. Autoimmunity (1988) 1.13